New Haven, CT 的 前列腺癌 臨床試驗
20 項針對 前列腺癌 的研究正在 New Haven（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
招募中1/2 期
- GSK Investigational Site, New Haven
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
招募中1/2 期
- Yale Cancer Center, New Haven
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
招募中2 期
- Yale Cancer Center, New Haven
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
招募中1/2 期
- Yale University, New Haven
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
招募中3 期
- Yale-New Haven Hospital-Yale Cancer Center ( Site 0064), New Haven
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
招募中2 期
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven · 距離 3 英里
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
招募中3 期
- Yale-New Haven Hospital-Yale Cancer Center ( Site 0050), New Haven
- Veterans Affairs Connecticut Healthcare System ( Site 0062), West Haven · 距離 3 英里
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
招募中2 期
- Yale Cancer Center, New Haven
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
招募中1 期
- Yale Cancer Center, New Haven
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
招募中1 期
- Yale New Haven Hospital, New Haven
A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng/ml Using Biopsy as the Sole Ground Truth
招募中觀察性研究
- Wren Laboratories, Branford · 距離 6 英里
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- Yale University School of Medicine, New Haven
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
招募中2 期
- New Haven Hospital - Yale Cancer Center, New Haven
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
招募中1 期
- Yale New Haven Hospital, New Haven
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
招募中3 期
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · 距離 3 英里
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
招募中1/2 期
- Yale University (Data Collection Only), New Haven
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
招募中觀察性研究
- Yale University, New Haven
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
招募中1/2 期
- Yale University, Yale Cancer Center, New Haven
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
招募中2 期
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 距離 7 英里
- 還有 2 項
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
招募中3 期
- Yale University, New Haven
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · 距離 3 英里
- Smilow Cancer Hospital Care Center - Guilford, Guilford · 距離 13 英里
其他城市的 前列腺癌 試驗
- New York City, NY103 項研究
- Houston, TX76 項研究
- Los Angeles, CA61 項研究
- Boston, MA59 項研究
- St. Louis, MO46 項研究
- Chicago, IL45 項研究
- San Francisco, CA45 項研究
- Philadelphia, PA44 項研究
- Baltimore, MD43 項研究
- Nashville, TN43 項研究
- Seattle, WA42 項研究
- Washington, DC38 項研究
New Haven 的其他研究
- 非小細胞肺癌41 項研究
- 乳癌38 項研究
- 癌症（所有類型）33 項研究
- 轉移性癌症23 項研究
- 肺癌22 項研究
- 頭頸部鱗狀細胞癌22 項研究
- 卵巢癌21 項研究
- 大腸直腸癌20 項研究
- 急性髓系白血病17 項研究
- 酒精使用障礙 (AUD)17 項研究
- 鴉片類藥物過量17 項研究
- 胰臟癌16 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。